WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics
Inc. (MYGN):

Earnings: -$116.1 million in Q2 vs. -$14.1 million in the same period last year.
EPS: -$1.42 in Q2 vs. -$0.18 in the same period last year.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$6.4
million or -$0.08 per share for the period.

Analysts projected -$0.08 per share
Revenue: $183.5 million in Q2 vs. $179.3 million in the same period last year.

-Guidance:
Full year EPS guidance: $(-0.36) - $(-0.24)
Full year revenue guidance: $730 - $750 Mln


Copyright(c) 2023 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX